Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging

Neuroradiology

Volumn 48, Issue 10, 2006, Pages 773-781

  Ding, Bei ^a   Ling, Hua Wei ^a   Chen, Ke Min ^a   Jiang, Hong ^a   Zhu, Yan Bo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Computed tomography; Diagnostic techniques; Glioma; Perfusion

Indexed keywords

IOHEXOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; BRAIN PERFUSION; BRAIN REGION; BRAIN TISSUE; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DATA ANALYSIS SOFTWARE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLIOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; MALE; PATIENT CARE; PERFUSION WEIGHTED IMAGING; PERMEABILITY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; BLOOD VOLUME; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; FEMALE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749339281     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-006-0120-1     Document Type: Article

References (35)

1. Miles KA (2002) Functional computed tomography in oncology. Eur J Cancer 38:2079-2084
2. Miles KA, Charnsangavej C, Lee FT et al (2000) Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 7:840-850
3. Gillard JH, Antoun NM, Burnet NG et al (2001) Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74:552-555
4. 15O positron emission tomography. Neurol Res 22:457-464
5. Figarella-Branger D, Bouvier C (2005) Histological classification of human gliomas: State of art and controversies. Bull Cancer 92:301-309
6. Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645
7. Thiessen B, Maguire JA, McNeil K (2003) Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: Relationship to outcome and chemosensitivity. J Neurooncol 64:271-278
8. Thorpe PE, Chaplin DJ, Blakey DC (2003) The first international conference on vascular targeting: Meeting overview. Cancer Res 63:1144-1147
9. Galbraith SM (2001) Combretastatin A4 phosphate (CA4P) reduces tumor blood flow in animals and man, demonstrated by MRI. Proc Am Soc Clin Oncol 20:278a
10. Shih SC, Mullen A, Abrams K et al (1999) Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274:15407-15414
11. Barker FG II, Chang SM, Huhn SL et al (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80:936-941
12. Scott JN, Brasher PM, Sevick RJ et al (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947-949
13. Chaudhry IH, O'Donovan DG, Brenchley PE et al (2001) Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39:409-415
14. Machein MR, Plate KH (2000) VEGF in brain tumors.J Neurooncol 50:109-120
15. Toi M, Matsumoto T, Bando H (2001) Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2:667-673
16. Daumas-Duport C, Varlet P, Tucker ML (1997) Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurooncol 34:37-59
17. Guha A, Mukherjee J (2004) Advances in the biology of astrocytomas. Curr Opin Neurol 17:655-662
18. Amoroso A (1997) Vascular endothelial growth factor: A key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17-25
19. Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 191:41-51
20. Weidner N, Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167-190
21. Dvorak HF, Nagy JA, Feng D et al (1999) Vascular permeability factor/ vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97-132
22. Taylor JS, Tofts PS, Port R et al (1999) MR imaging of tumor microcirculation: Promise for the new millennium. J Magn Reson Imaging 10:903-907
23. Roberts HC, Roberts TP, Brasch RC et al (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histologic grade. AJNR Am J Neuroradiol 21:891-899
24. Provenzale JM, Wang GR, Brenner T et al (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711-716
25. Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755
26. Griebel J, Mayr NA, de Vries A et al (1997) Assessment of tumor microcirculation: A new role of dynamic contrast MR imaging.J Magn Reson Imaging 7:111-119
27. Maia, AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26:777-783
28. Jackson A, Kassner A, Annesley-Williams D et al (2002) Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: Comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23:7-14
29. Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathological grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 179:783-789
30. Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501-523
31. Lev MH, Ozsunar Y, Henson JW et al (2004) Elevated relative cerebral blood volume of oligodendrogliomas: A confounder of glial tumor grading specificity using dynamic spin-echo MR susceptibility mapping. AJNR Am J Neuroradiol 25:214-221
32. Diego JC, Bruce RR, Michael HL (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528-537
33. Lupo JM, Cha S, Chang SM et al (2005) Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: Characterization of spatial heterogeneity. AJNR Am J Neuroradiol 26:1446-1454
34. Mukonoweshuro W, Herwardkar A, Jackson A (2002) Imaging of intracranial tumours. Imaging 14:380-395
35. Provenzale JM, Mukundan S, Dewhirst M (2005) The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 185:763-767